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Abstract 
The ability to precisely manipulate the genome in a targeted manner is fundamental to driving 
both basic science research and development of medical therapeutics. Until recently, this has 
been primarily achieved through coupling of a nuclease domain with customizable protein 
modules that recognize DNA in a sequence-specific manner such as zinc finger or transcription 
activator-like effector domains. Though these approaches have allowed unprecedented precision 
in manipulating the genome, in practice they have been limited by the reproducibility, 
predictability, and specificity of targeted cleavage, all of which are partially attributable to the 
nature of protein-mediated DNA sequence recognition. It has been recently shown that the 
microbial CRISPR-Cas system can be adapted for eukaryotic genome editing. Cas9, an RNA-
guided DNA endonuclease, is directed by a 20-nt guide sequence via Watson-Crick base-pairing 
to its genomic target. Cas9 subsequently induces a double-stranded DNA break that results in 
targeted gene disruption through non-homologous end-joining repair or gene replacement via 
homologous recombination. Finally, the RNA guide and protein nuclease dual component 
system allows simultaneous delivery of multiple guide RNAs (sgRNA) to achieve multiplex 
genome editing with ease and efficiency.  
 
The potential effects of off-target genomic modification represent a significant caveat to genome 
editing approaches in both research and therapeutic applications. Prior work from our lab and 
others has shown that Cas9 can tolerate some degree of mismatch with the guide RNA to target 
DNA base pairing. To increase substrate specificity, we devised a technique that uses a Cas9 
nickase mutant with appropriately paired guide RNAs to efficiently inducing double-stranded 
breaks via simultaneous nicks on both strands of target DNA. As single-stranded nicks are 
repaired with high fidelity, targeted genome modification only occurs when the two opposite-3 
 
strand nicks are closely spaced. This double nickase approach allows for marked reduction of 
off-target genome modification while maintaining robust on-target cleavage efficiency, making a 
significant step towards addressing one of the primary concerns regarding the use of genome 
editing technologies.  
 
The ability to multiplex genome engineering by simply co-delivering multiple sgRNAs is a 
versatile property unique to the CRISPR-Cas system. While co-transfection of multiple guides is 
readily feasible in tissue culture, many in vivo and therapeutic applications would benefit from a 
compact, single vector system that would allow robust and reproducible multiplex editing. To 
achieve this, we first generated and functionally validated alternate sgRNA architectures to 
characterize the structure-function relationship of the Cas9 protein with the sgRNA in DNA 
recognition and cleavage. We then applied this knowledge towards the development and 
optimization of a tandem synthetic guide RNA (tsgRNA) scaffold that allows for a single 
promoter to drive expression of a single RNA transcript encoding two sgRNAs, which are 
subsequently processed into individual active sgRNAs.  
 
 
 
   4 
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Background  
Biology began with observational studies that catalogued behaviors and physiological 
characteristics of living organisms. These early studies established the cell as the smallest unit of 
life capable of self-replication and the gene as the basic unit of heritable traits. It was from these 
realizations that we first appreciated that there exists in every single organism a genome, which 
is passed from generation to generation that carries all the instructions of life: how to look, 
reproduce, behave, and even interact with its surroundings. And so began the ongoing search for 
connecting genotype to phenotype.  
 
Two important advances in the last several decades have propelled our understanding of 
molecular processes far beyond descriptions of biology at macroscopic levels and fundamentally 
altered the way that we comprehend organisms, tissues, and cells. First, growing hand in hand 
with the exponential expansion of computing power, the development of genome sequencing 
technology, enabling high resolution mapping of DNA sequences, has allowed us to define, 
down to the nucleotide level, differences between multiple species, members of a species, and 
within an individual, between classes of cells, as well as diseased and malignant cells. At this 
point, our ability to make sense of this wealth of genomic information is only limited by our 
ability to make ever-more precise cellular and genomic alterations to which we may ascribe a 
phenotypic change. To achieve this, we have concurrently created tools that have allowed us to 
query the functions of genes and genetic variations from scales large to small by means of first 
random and then targeted mutagenesis, followed by increasingly refined means of manipulating 
either the genome directly or the activity of the genes themselves at the level of RNA or protein. 
This ongoing effort to develop ever more effective, precise, and adaptable means of modifying 
the genome is the focus of this thesis.  8 
 
Development of genome engineering technologies 
Endogenous locus gene targeting, the deliberate replacement of genetic material with alternative 
sequences by taking advantage of the endogenous homology-directed repair (HDR) mechanism, 
has been and remains today the gold standard for functional analyses of genes and variants 
1. The 
co-opting of homologous recombination machinery as a means of introducing exogenous DNA 
into a targeted locus was first demonstrate in mice in the late 1980s 
2 and in human cells soon 
thereafter
3. However, this approach was initially extremely limited by the very low frequency 
with which HDR templates are incorporated into the genome and complicated by off-target 
insertions, requiring time and labor-intensive screening procedures to ensure proper clone 
selection.  
 
A key breakthrough was the realization that double-stranded DNA breaks (DSBs) greatly 
stimulated cellular DNA repair mechanisms, shown first in yeast
4 and then in mammalian cells
5,6. 
DSBs are typically repaired within a cell using one of two pathways: non-homologous end-
joining (NHEJ) or homologous recombination
7. The former simply joins the broken ends of the 
DNA, often creating small insertion or deletion mutations (indels); the latter uses a homologous 
template to replace the broken region. Thus, the induction of DSBs in cells stimulates both 
targeted mutagenesis as well as gene targeting. 
 
The initial experiments demonstrating the utility of DSB for gene replacement strategies 
depended on the use of naturally occurring endonucleases with long DNA recognition 
sequences
6. However, these highly site-specific enzymes were of limited practical utility for 
targeting any given genomic loci at will. 
 9 
 
A programmable genome editing tool fundamentally consists of two key elements: a DNA-
recognition domain conferring target specificity and a nuclease domain, ideally without any 
sequence specificity on its own. A key breakthrough came with the observation that the 
restriction enzyme FokI has molecularly distinct binding and cleavage domains
8, and that 
swapping of recognition domains could alter FokI targeting specificity
9. Prior to this realization, 
zinc fingers were discovered as a class of protein motifs in X. laevi
10, and found to be frequently 
occurring in mammalian cells as transcription factors where bind DNA in a modular, sequence-
specific manner
11,12. Each individual module of a Cys2-His2 zinc finger domain, the most 
commonly used ZF-type domain in genome engineering applications, contains approximately 30 
amino acids that fold to interact with 3-bp of DNA.  
 
With the creation of custom zinc-finger arrays capable of targeting any DNA sequence, either 
through stringing together of pre-defined modules with known, predicted 3bp-binding affinity
13 
or selection-based protocols with randomized ZF array libraries to account and optimize for 
inter-modular interactions
14, the pairing of the DNA-targeting ZF and FokI nuclease components 
created a new class of zinc finger nucleases (ZFNs) that quickly proved to be an adaptable and 
efficient method for targeting specific genomic loci in a variety of model organisms
15. While 
zinc finger technology can in theory target any specific genomic sequence, the difficulty of 
accurately predicting protein conformational folding and DNA-protein interactions prior to array 
assembly can make ZFN construction a somewhat tedious and costly process involving a 
substantial validation phase prior to practical use.  
 
More recently, an analogous, simpler alternative was developed following the deciphering of the 
DNA recognition patterns of another class of proteins: the transcription activator-like effector 10 
 
proteins (TALEs)
16,17. First observed in the rice pathogen Xanthomonas, these proteins consisted 
of naturally occurring modular arrays of 33-35 amino acid domains, each interacting with a 
single basepair.  Although the single base discrimination of TALE modules compared to 3bp-
recognition in ZF domains provides greater ease and flexibility in designing TALE arrays to 
genomic targets, the inherently repetitive nature of TALE repeats posed a technical challenge 
that required the development of new assembly methodologies
18. Even so, given the modular 
separation of DNA recognition activity from nuclease or other effector domains, TALE-derived 
proteins have been able to quickly co-opt existing technology generated by the studies involving 
ZF proteins to similarly demonstrate effective genome editing capabilities in a wide variety of 
model organisms and systems
19-21.  
 
One of the major limitations of the aforementioned genome-engineering technologies is their 
intrinsic dependence on protein-DNA interactions to drive specificity. As such, even after 
following rational design or thorough in vitro selection processes, it is necessary to perform 
extensive in vitro validation as protein activity and affinity may vary depending on the specific 
context in unpredictable ways. Practically, these factors necessitate the construction of multiple 
sets of TALENs or ZFNs for each locus targeted and, as a consequence, make high-throughput 
screening applications less tractable.  
 
Although not directly manipulating the genome, the use of small-interfering RNAs (siRNA) to 
modulate gene expression represents a powerful alternative technology that is not bound by 
many of the short-comings of these existing genome editing technologies and revolutionized our 
ability to functionally interrogate the genome
22. The foundational observation was first made in 
C. elegans, that the introduction of double-stranded RNA into a cell results in potent post-11 
 
transcriptional silencing of gene or genes carrying sequences complementary to the exogenous 
sequence
23. There are a number of key features that made the RNAi approach particularly 
tractable and drove its widespread and rapid adoption in basic science research. Firstly, RNAi is 
an extremely efficient method of gene silencing. It is not uncommon to achieve greater than 85% 
gene knockdown, which, while not complete, is often more than sufficient for inducing a 
phenotype by which to assess gene function
22. Secondly, siRNA targeting is mediated by 
predictable Watson-Crick base-pairing. This has allowed the elucidation of design parameters to 
both maximize on-target silencing and minimize off-target effects
24. Additionally, the relative 
ease of designing and creating siRNA constructs allows for rapid prototyping and validation of 
new targets. Thirdly, the mechanism of siRNA action takes advantage of a highly-conserved 
endogenous pathway for processing small RNAs
25, which minimizes the amount of material that 
needs to be delivered for adequate effect. This has had a number of key impacts including but not 
limited to the possibility of multiplexed delivery to silence more than a single gene
26,27 at a time 
or to target a single gene with multiple siRNAs to maximize knock-down
28, as well as the 
generation of large siRNA libraries allowing the development of high-throughput screening 
methodologies for rapid phenotyping in different contexts
29,30. Taken together, although not 
without its drawbacks, the efficacy, predictability, and generalizability of RNAi technologies 
provided it with enough compelling qualities to become a truly disruptive technology in the field 
of genome engineering.  
 
Re-purposing the bacterial CRISPR/Cas system for genome editing 
The RNA-guided CRISPR (clustered regularly interspaced short palindromic repeats) 
endonuclease system was first observed in E. coli in 1987 by its striking eponymous genomic 
structure
31  Evolved as an adaptive immune system, bacteria and archaea use a set of CRISPR-12 
 
associated (Cas) genes to incorporate exogenous material into the CRISPR locus, and 
subsequently transcribe them as RNA templates for targeted destruction of the mobile elements 
at either DNA or RNA level
32. 
Three types of CRISPR systems have been identified to date, differing in their targets as well as 
mechanisms of action. Type I and III CRISPR systems employ an ensemble of Cas gene to carry 
out RNA processing, recognition of target, and cleavage
33,34. By contrast, the type II CRISPR-
Cas system makes use of a single endonuclease, Cas9, to locate and cleave target DNA
35,36. Cas9 
is guided by a pair non-coding RNAs, a guide-bearing and variable crRNA and a required 
auxiliary transactivating crRNA (tracrRNA)
37. The crRNA contains a 20-nt guide sequence, also 
known as a spacer, that determines target specificity by via Watson-Crick base-pairing with 
target DNA, followed by the invariant “direct repeat” portion that base-pairs with the “anti-
repeat” portion of the tracrRNA to form an RNA duplex. In the native bacterial system, multiple 
crRNAs are co-transcribed as a pre-crRNA array before being processed down to individual 
units for directing Cas9 against various targets
37. In the CRISPR-Cas system derived from 
Streptococcus pyogenes, the target DNA sequence always precedes a 5’-NGG protospacer 
adjacent motif (PAM), which can differ depending on the CRISPR system
38. 
The S. pyogenes CRISPR-Cas system was the first to be reconstituted in mammalian cells 
through the heterologous expression of human codon-optimized Cas9 and the two RNA 
components
39,40. By altering the the 20-nt guide sequence within the sgRNA, Cas9 can be re-
directed toward any target bearing an appropriate PAM. Furthermore, elements from the crRNA 
and tracrRNA can be artificially linked to create a chimeric, single guide RNA (sgRNA)
1,41, 
further simplifying the system for eukaryotic gene targeting.  
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At an overall structural level, Cas9 contains two nuclease domains, HNH and RuvC, each of 
which cleaves one strand of the target DNA
41,42. A mutation in either one of its catalytic domains 
converts Cas9 nuclease into a nickase, which has shown to induce single-stranded breaks for 
high-fidelity HDR applications, potentially ameliorating unwanted indel mutations from off-
target DSBs
39,40. Finally, a catalytically inactive or dead Cas9 (dCas9) with mutations in both 
DNA-cleaving catalytic residues can serve as an RNA-guided DNA-binding scaffold for 
localizing target effector domains that gene expression at the transcriptional level
43-47. 
 
Obstacles and concerns regarding utilization of genome engineering technologies 
Recent studies of Cas9 specificity have shown that although each base within the 20-nt guide 
sequence contributes to overall specificity, multiple mismatches between the guide RNA and its 
complementary DNA can be tolerated in a quantity-, position-, and base identity-sensitive 
manner
39,48,49. As a result, Cas9 can cleave genomic loci that share imperfect homology with the 
target 20-nt guide sequence, leading to off-target DSBs and NHEJ repair. Subsequent indel 
formation at off-target cleavage sites can lead to significant levels of unwanted mutations, which 
limit the utility of Cas9 for genome editing applications requiring high levels of precision, 
including generation of isogenic cell lines for testing causal genetic variations as well as in vivo 
and ex vivo genome editing-based therapies. 
 
 To improve the specificity of Cas9-mediated genome editing, I describe in this thesis the 
development a novel strategy that combines the D10A mutant nickase
39,41,42 version of Cas9 
(Cas9n) with a pair of offset sgRNAs targeting opposite strands of the target site. Nicking of 
both DNA strands at the target site by a pair of Cas9 nickases leads to site-specific DSBs, while 
individual nicks are predominantly repaired by the high-fidelity base excision repair pathway 14 
 
(BER) as opposed to error-prone NHEJ
50. This strategy would minimize off-target mutagenesis 
by each Cas9n-sgRNA complex while maximizing on-target NHEJ comparable to wild-type 
Cas9 and would be analogous to dimeric zinc finger nucleases (ZFNs)
51 and transcription 
activator-like effector nucleases (TALENs)
16, where DNA cleavage relies upon the synergistic 
interaction of two independent specificity-encoding modules. ZFNs and TALENs generate DSBs 
through the proximity-induced dimerization of two FokI monomers, each of which nicks one 
DNA strand. Similarly, we paired Cas9n with two sgRNAs targeting opposite strands of a 
desired locus. This ‘double nicking’ strategy would effectively magnify the targeting specificity 
of Cas9 by requiring simultaneous targeting by two sgRNAs. 
 
Finally, to facilitate the co-delivery of multiple sgRNA, I describe our efforts to develop a 
system for expressing pairs of sgRNAs under a single promoter. We first aim to understand the 
structural components of sgRNA critical for function, and secondly use this knowledge to inform 
our design of sequence-divergent new sgRNA scaffolds that facilitate tandem sgRNA 
transcription.   15 
 
Materials and Methods 
PCR amplification of U6-promoter-driven sgRNAs and tandem sgRNAs. 
Spacer selection for targeting by Cas9 and subsequent generation of PCR amplicon was 
performed as described in Ran et al
52. Briefly, oligo ultramers consisting of U6 priming site, 
spacer sequence, and guide RNA scaffold were synthesized by IDT for amplification of U6-
driven PCR cassettes for cellular transfections. In both cases, either QiaQuick (Qiagen) or 
EconoSpin (Epoch Life Sciences) spin columns were used to clean up PCR reactions prior to 
transfections. Tandem sgRNA are synthesized in a 2-round PCR as follows: Round 1: 
Amplification using U6 promoter as template, U6-Fwd primer (as in previous PCR expression 
cassette experiments for sgRNA delivery), and a modified Reverse primer that contains from 5’ 
to 3’ (in reverse complement direction): spacer-2, sgRNA modified scaffold, spacer-1, U6 
priming region. Round 2: Amplifies using product from round 1 as template, using U6-Fwd 
primer as previously described, and a reverse primer 5’ to 3’ (in reverse complement direction): 
modified scaffold, spacer-2. After 2 rounds of PCR, the full-length tsgRNA product is purified 
and co-transfected with Cas9 for testing in cells. In both cases, either QiaQuick (Qiagen) or 
EconoSpin (Epoch Life Sciences) spin columns were used to clean up PCR reactions prior to 
transfections. A list of the sgRNAs used and their genomic targets can be found in Table 2.  
 
Cell culture and transfection 
Human embryonic kidney (HEK) cell line 293FT (Life Technologies) was maintained in 
Dulbecco’s modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum 
(HyClone), 2mM GlutaMAX (Life Technologies), 100U/mL penicillin, and 100µg/mL 
streptomycin at 37°C with 5% CO2 incubation. Cells are passaged at regular intervals and 16 
 
seeded onto 24-well plates (Corning) at a density of 120,000 cells/well, 24 hours prior to 
transfection. Cells were transfected using Lipofectamine 2000 (Life Technologies) at 80-90% 
confluency per manufacturer recommended protocol: A total of 400ng Cas9 plasmid and 100 ng 
of U6-sgRNA PCR product was transfected per well of a 24-well plate. For double-nicking 
experiments or transfections involving more than a single guide, 100ng of each sgRNA was 
transfected. In the case of tandem sgRNAs, 200ng of purified U6-tsgRNA PCR product was 
transfected per well.  
 
Human embryonic stem cell line HUES62 (Harvard Stem Cell Institute core) was maintained in 
feeder-free conditions on GelTrex (Life Technologies) in mTesR medium (Stemcell 
Technologies) supplemented with 100ug/ml Normocin (InvivoGen). HUES62 cells were 
transfected with Amaxa P3 Primary Cell 4-D Nucleofector Kit (Lonza) following the 
manufacturer’s protocol. 
 
SURVEYOR nuclease assay for genome modification 
293FT and HUES62 cells were transfected with DNA as described above. Cells were incubated 
at 37ºC for 72 hours post-transfection prior to genomic DNA extraction. Genomic DNA was 
extracted using the QuickExtract DNA Extraction Solution (Epicentre) following the 
manufacturer’s protocol. Briefly, pelleted cells were resuspended in QuickExtract solution and 
incubated at 65ºC for 15 minutes, 68°C for 15 minutes, and 98ºC for 10 minutes. 
 
The genomic region flanking the CRISPR target site for each gene was PCR amplified (primers 
listed in Table 4), and products were purified using QiaQuick Spin Column (Qiagen) following 17 
 
the manufacturer’s protocol. 400ng total of the purified PCR products were mixed with 2ml 10X 
Taq DNA Polymerase PCR buffer (Enzymatics) and ultrapure water to a final volume of 20ml, 
and subjected to a re-annealing process to enable heteroduplex formation: 95ºC for 10min, 95ºC 
to 85ºC ramping at – 2ºC/s, 85ºC to 25ºC at – 0.25ºC/s, and 25ºC hold for 1 minute. After re-
annealing, products were treated with SURVEYOR nuclease and SURVEYOR enhancer S 
(Transgenomics) following the manufacturer’s recommended protocol, and analyzed on 4-20% 
Novex TBE poly-acrylamide gels (Life Technologies). Gels were stained with SYBR Gold DNA 
stain (Life Technologies) for 30 minutes and imaged with a Gel Doc gel imaging system (Bio-
rad). Quantification was based on relative band intensities. Indel percentage was determined by 
the formula, 100 x (1 - (1 - (b + c) / (a + b + c))1/2), where a is the integrated intensity of the 
undigested PCR product, and b and c are the integrated intensities of each cleavage product. 
 
Deep sequencing to assess targeting specificity 
HEK 293FT cells were plated and transfected as described above, 72 hours prior to genomic 
DNA extraction. The genomic region flanking the CRISPR target site for each gene was 
amplified (primers listed in Table 5) by a fusion PCR method to attach the Illumina P5 adapters 
as well as unique sample-specific barcodes to the target. PCR products were purified using 
EconoSpin 96-well Filter Plates (Epoch Life Sciences) following the manufacturer’s 
recommended protocol. 
 
Barcoded and purified DNA samples were quantified by Qubit 2.0 Fluorometer (Life 
Technologies) and pooled in an equimolar ratio. Sequencing libraries were then sequenced with 
the Illumina MiSeq Personal Sequencer (Life Technologies). 
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Sequencing data analysis, indel detection, and homologous recombination detection 
MiSeq reads were filtered by requiring an average Phred quality (Q score) of at least 30, as well 
as perfect sequence matches to barcodes and amplicon forward primers. Reads from on- and off-
target loci were analyzed by performing Ratcliff-Obershelp string comparison, as implemented 
in the Python difflib module, against loci sequences that included 30 nucleotides upstream and 
downstream of the target site (a total of 80 bp). The resulting edit operations were parsed, and 
reads were counted as indels if insertion or deletion operations were found. Analyzed target 
regions were discarded if part of their alignment fell outside the MiSeq read itself or if more than 
5 bases were uncalled. 
 
Negative controls for each sample provided a gauge for the inclusion or exclusion of indels as 
putative cutting events. For quantification of homologous recombination, reads were first 
processed as in the indel detection workflow, and then checked for presence of homologous 
recombination template CCAGGCTTGG. 
 
Flow cytometric analysis for Cas9 self-targeting indel induction 
Cells were transfected as above using the Cas9 plasmid PX475 encoding SpCas9-t2a-GFP in the 
presence of guide RNAs targeting Cas9 itself. Three days following transfection, cells were 
washed once with PBS, trypsinized and triturated to single cell suspension, and re-suspended in 
PBS buffer supplemented with 5% FBS and 2mM EDTA. Fluorescent intensity was 
subsequently measured using the Accuri C6 flow cytometer.  
 19 
 
Northern blot analysis of sgRNA processing 
Cells were transfected as described above and incubated for 72 hrs at 37C. RNA was 
subsequently extracted from the cells per mirVana miRNA isolation kit protocol (Life 
Technologies) to enrich for small RNAs. Purified small RNAs were resolved on a denaturing gel, 
transferred to BrightStar Positively-Charged Nylon Membrane (Ambion), and probed overnight 
using radioactive or biotinylated oligonucleotides targeted against specific sgRNA spacer 
sequences. Visualization was performed through the use of a Typhoon imager or Li-Cor CLx 
machine depending on probe modality. 
   20 
 
Results 
Cas9 nickase generates efficient NHEJ with closely approximated dual guide RNAs   
The targeting specificity and activity of the Cas9 nuclease is dependent on base-pairing 
interaction between the 20nt guide sequence within the sgRNA and the target DNA. We 
therefore reasoned that lengthening the guide sequence might increase guide:target basepairing 
and increase Cas9 targeting specificity. However, this failed to improve Cas9 targeting 
specificity as a majority of the lengthened guide sequence is processed back to a 20-nt length
53. 
We therefore explored an alternate strategy for increasing the overall base-pairing length 
between guide sequence and DNA target based on simultaneous nicking of both strands of DNA 
by two separate Cas9-sgRNA complexes. Single-strand nicks by Cas9n are preferentially 
repaired by the BER pathway, which typically results in extremely low levels of mutagenesis
50  
We reasoned that two nicking enzymes directed by a pair of sgRNAs targeting opposite strands 
of a target locus, requiring double the number of sgRNA bases paired to target DNA, might still 
be able to mediate DSBs while loci nicked by a single sgRNA-Cas9 duplex would be perfectly 
repaired (schematized in Figure 1A). By co-transfecting sgRNAs and the Cas9 D10A nickase 
(Cas9n), which nicks the strand of DNA complementary to the sgRNA, into human embryonic 
kidney (HEK293FT) cells, we observed that whereas Cas9n in combination with guide pairs 
could efficiently induce indel formation, Cas9n with single guides alone did not result in 
detectable modification of the target locus by SURVEYOR assay (Figure 1B).  
 
 Given that the double-nicking strategy requires two Cas9n-sgRNA complexes to simultaneously 
target the same locus, steric hindrance is likely to be of concern in determining whether any pair 
of sgRNAs targeting opposite strands of DNA may be used for generating DSBs. To thoroughly 
characterize the parameters of paired guide RNAs that would be amenable to indel formation, we 21 
 
systematically designed sgRNA pairings targeting three different human genes separated by a 
range of offset distances from -200 to 200 bp, creating both 5’- and 3’-overhang products, and 
tested each for NHEJ (pairs listed in Table 1). Significantly, across all three genes, we observed 
substantial indel frequency (up to 40%) for sgRNA pair offsets from -4 to 20 bp (Figure 2A). 
Notably, indels formed by double-nicking with paired guide RNAs can result in larger and more 
varied types of mutations (representative indels observed by deep sequencing shown in Figure 
2B) than usually observed with single guides, which typically result in small deletions in the 
target sequence 4-6 bp upstream from the PAM
48. Occasionally, sgRNAs offset by up to 100 bp 
were observed to mediate on-target modification, which suggests a wide range of possible 
spacings for targeting. Importantly, all single sgRNAs transfections with wild-type Cas9, but not 
Cas9n, mediated efficient indel formation (summarized in Table 1), consistent with relative 
spacing between guide pairs being the primary determinant of double-nickase induced genome 
modification. Impressively, double nickase indel frequencies were generally comparable to those 
mediated by wild-type Cas9 nuclease targeting the same locus. Taken together, these results 
indicate that double nicking can serve as a generalizable and predictable solution for efficiently 
mediating precisely targeted DSBs.  
 
Double nicking allows high-efficiency homologous recombination 
While induction of double-stranded DNA breaks can introduce mutagenic indels at targeted 
genomic loci and mediate gene knockout, it can also be a mechanism by which to facilitate 
homology directed repair (HDR) to enable highly precise editing or gene replacement of target 
sites. Given the wealth of SNP data that is being generated and the increasing association with 
and appreciation of small or single base-pair mutations in disease tissues through genome- or 
exome-wide sequencing efforts
54,55, the ability to reliably and efficiently alter small genomic 22 
 
regions for downstream functional testing or disease modeling would prove enormously useful.  
 
Previously, our lab has shown that Cas9n, when used with a single sgRNA to nick DNA, can 
initiate HDR 
39. However, HDR occurs at a much lower frequency when mediated by nicking 
rather than DSB, which can further vary among cell types
52. To test the efficiency of HDR with 
using a double-nicking strategy, we targeted the human EMX1 locus with two pairs of sgRNAs 
offset by -3 and 17 bp (generating 31- and 52-bp 5’ overhangs, respectively) and introduced a 
single-stranded oligonucleotide (ssODN) bearing a HindIII restriction site as the HDR repair 
template in order to introduce a restriction fragment length polymorphism (RFLP) into the 
genomic locus (Figure 3A). Subsequent RFLP demonstrated that both sgRNA pairs were able to 
successfully introduce the HR template at frequencies significantly higher than those of single-
guide Cas9n transfections and comparable to those of wild-type Cas9 (Figure 3B).  
 
The growing interest and development in stem cells (ESC) or patient derived induced pluripotent 
stem cells (iPSC) biology represents simultaneously a key opportunity for generating new 
disease paradigms and developing new therapeutics, as well as an increasing need to develop 
ever more precise and efficient means of genome modification. While double-stranded breaks 
have been shown to efficiently facilitate HDR in ESC and iPSCs, there is still much interest in 
using nicking approaches for HDR in these sensitive applications due to their lower off-target 
activity
56. However, single nick approaches to inducing HDR in human embryonic stem cells 
using the CRISPR-Cas system have met with limited success
48,52. To improve HDR efficiency in 
ES cells, we subsequently attempted double-nicking induced HDR in the HUES62 cell line 
observed significantly increased rates of incorporation of the HDR template (Figure 3C).  
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Analogous to defining optimal sgRNA spacing for indel generation by double-nicking, we next 
sought to determine the ideal parameters for potentiating HDR. We posited that to most 
efficiently facilitate strand invasion and subsequent conversion, at least one of the sgRNA paired 
RNAs should be targeted close to the site of integration. We tested a variety of sgRNA pairs 
wherein at least one of the targeted cleavage sites was close to the site of recombination (Figure 
4). We observed that sgRNA pairs predicted to generate a 5’ overhang with at least one target 
within 22bp of the site of integration were able to incorporate the provided HDR template at 
frequencies comparable to wild-type Cas9 nuclease mediated HDR. In contrast, sgRNA pairs 
that targeted the same strand of DNA, spaced by negative offsets, or that had neither sgRNAs 
close to the site of integration were unable to facilitate HDR at detectable levels.   
 
 Double nicking mediates highly specific genome editing 
Having shown that double-nicking mediates high efficiency induction of both NHEJ and HDR at 
levels comparable to those induced by wild-type Cas9, we next sought to determine whether this 
approach results in improved specificity over Cas9 through quantification of off-target activities. 
We co-delivered Cas9n with two sgRNAs spaced by a 23-bp offset to target the human EMX1 
locus (Figure 5A). As expected, this configuration of paired sgRNAs resulted in on-target indel 
levels comparable to those of wild-type Cas9 transfected with either sgRNA singly (Figure 5B, 
left panel). Strikingly, we did not detect any modification by SURVEYOR assay at one of the 
sgRNA 1 off-target sites (OT-4) in the case of double-nicking where the wild-type Cas9 showed 
10% modification (Figure 4B, right panel). We subsequently used deep sequencing to assess 
modification at 5 different sgRNA 1 off-target loci and observed significant mutagenesis at all 
sites with wild-type Cas9 + sgRNA 1 alone (Figure 4C). In contrast, off-target cleavage by 
Cas9n was barely detectable and difficult to distinguish from sequencing error. Normalized to a 24 
 
specificity ratio (on- to off-target indel percentage ratio), Cas9n with two sgRNAs could achieve 
over 100-fold greater specificity relative to wild-type Cas9 (Figure 4D). 
 
In summary, the strategy of using the nickase Cas9n with closely approximated pairs of guide 
RNAs is as efficient at inducing NHEJ and facilitating HDR as the wild-type nuclease, while 
achieving much higher targeting specificity. Furthermore, the relatively wide range of off-set 
distances between the double guides that is compatible with robust activity renders double-
nicking an attractive and easily implemented method.  
 
Systematic mutagenesis of sgRNA architecture identifies regions for further optimization 
One of the critical elements of the type II CRISPR-Cas nuclease system is the trans-activating 
crRNA (tracrRNA), which shares partial sequence homology and base-pairs with the repeat 
region of the crRNA and is required for the assembly of the final Cas9-crRNA-tracrRNA 
complex 
37. While elements from tracrRNA and crRNA have been adapted to form a single 
artificially linked sgRNA (hereafter referred to as the wild-type sp85 scaffold) (Jinek Science, 
HSU), the effects of sgRNA scaffold modification and tolerance towards mutagenesis has in 
general not been comprehensively studied 
46,57. 
 
The sgRNA scaffold can be functionally and structurally divided into several components. The 
crRNA portion includes the guide sequence and the direct repeat regions. The tracrRNA begins 
with a 14-nt anti-repeat that partially basepairs with the direct repeat to form a stem loop (stem 
loop 1), and further contains an 18-bp linker to two additional stem loops (stem loop 2 and 3). 
Importantly, there are several unpaired bases within the direct repeat and tracrRNA anti-repeat 
stem loop 1, which create a bulge separating the proximal and distal direct repeat regions (Figure 25 
 
6A). We hypothesized that optimization of the sgRNA architecture could improve the genome 
editing activity of Cas9 and subsequently performed a systematic interrogation of the sgRNA 
scaffold to gain a better functional understanding of each component.  
 
We first identified regions of the sgRNA likely important for binding and recognition by Cas9. 
Strikingly, replacement of the stem loop 1 bulge with perfectly base-pairing sequences 
completely abolished Cas9-mediated indel activity, while substituting other non-base pairing 
nucleotides and thus retaining the bulge structure still allowed maintenance of modest activity. 
Within stem loop 1, mutations in the proximal direct repeat was not uniformly tolerated: whereas 
shortening the proximal direct repeat duplex or mutating the poly-T tract to mixed pyrimidines 
and purines abolished Cas9 activity, mutating the poly-T tract to pyrimidines alone was well-
tolerated (Figure 6B). Finally, truncation, shuffling, or randomization of the 18-bp linker 
sequence likewise resulted in complete loss of activity. However, it is possible that this longer 
linker forms additional secondary structures not predicted by RNA-folding
58, and further finer 
mapping mutagenesis experiments will be needed to elucidate its structural role. 
 
Consistent with previous studies showing that stem loops 2 and 3 are not critical for Cas9 
activity even though they significantly improve cleavage efficiency, alterations of the distal 
hairpins are largely well tolerated. For instance, both stem loops 2 and 3 could be largely 
replaced with G-C basepairs or extended in length without adversely affecting activity (Figure 
6B). Together, these findings suggest that while the proximal direct repeat, bulge, and linker may 
be involved in Cas9 recognition and binding, the two distal hairpins are likely more important for 
sgRNA folding and stability. Indeed, simultaneous stabilization of both distal hairpins along with 
mutating the distal direct repeat region was well tolerated, yielding indel activity comparable to 26 
 
the original scaffold (Figure 7).  
 
U6-driven tandem guide RNAs are able to deliver two functional sgRNAs 
The programmable nature of the CRISPR-Cas system by small RNAs makes it inherently more 
tractable than purely protein module-based tools such as ZFNs and TALENs for applications 
requiring multiplex targeting. Indeed, we and others have already shown that this can be readily 
achieved by co-delivering multiple sgRNAs in a variety of applications
39,59,60. While this 
approach works well for in vitro studies, in vivo or therapeutic applications would benefit from 
using a single vector system such as AAV. One of the major limitations of such systems is the 
amount genetic information that can be delivered (~4.8kb for AAV), above which the efficiency 
of AAV particle assembly rapidly declines
61. Furthermore, the alternative approach of using 
pooled delivery of independently transcribed sgRNAs is stochastic in nature and less 
reproducible than a single vector system, especially in applications where target saturation may 
not be desired or achievable. Many endogenous microbial CRISPR systems naturally occur as a 
single-promoter driven array of direct repeats interspaced by protospacers, which are transcribed 
as a single transcript prior to their processing into individual mature crRNAs
37. However, given 
that the chimeric sgRNA system works much more efficiently than the native crRNA:tracrRNA 
duplex
48, we sought to develop a system by which a single promoter may drive the expression of 
multiple sgRNAs arranged in tandem, similar to the native microbial CRISPR loci. 
 
We hypothesized that structurally stable sgRNA scaffolds would be more likely to fold into 
independent, functionally active units when multiple units are transcribed together in the same 
transcript. To test this, we began by inserting an 8-nt linker between tandem adjacent sgRNAs 
(Figure 8A); for each the invariant sgRNA scaffold (non-guide region), we used either pairs of 27 
 
original sp85 sgRNA or scaffolds with stabilized distal hairpins (4558 and 4561). Strikingly, we 
observed that when the tsgRNAs targeted closely approximated genomic loci previously shown 
to induce indels with Cas9 nickase, the stabilized scaffolds 4558 and 4561 were able to induce 
indels at frequencies similar to those induced by co-transfected individual sgRNAs (Figure 8B). 
Moreover, when paired with wild-type Cas9 nuclease, tsgRNAs were similarly able to induce 
genomic microdeletions in the human EMX1 locus at levels comparable to multiplexed, 
individual sgRNAs (Figure 8C).  
 
Optimization of tandem sgRNA scaffold architecture  
Having shown that sgRNAs transcribed in tandem are able to simultaneously target two genomic 
loci, we next sought to determine the optimal linker for connecting the adjacent guide-scaffolds. 
We designed tsgRNAs using linker sequences of varying lengths in a genomic microdeletion 
assay with two sgRNAs. Given that endogenous individual protospacers are separated by 36-nt 
long direct repeat sequences
37, we also tested linkers that encoded for either half of a direct 
repeat or a full-length direct repeat. Interestingly, we observed there was not a strong correlation 
between linker sequence length and the efficiency of genome modification, even in cases where 
there was no linker separating the distal end of the sgRNA from the guide sequence of the 
second (Figure 9). However, it appeared that inclusion of direct repeat sequences adversely 
affected activity while there’s a modest preference towards 12-nt linker length for cleavage 
efficiency, although more studies are needed to confirm these observations.  
 
Processing of tandem sgRNAS into individual subunits occurs, is position-dependent  
An obvious question to transcribing multiple sgRNAs under the same promoter is whether or not 28 
 
the co-transcribed tandem sgRNAs are processed to individual guide-scaffold units. To answer 
this, we designed tandem sgRNAs that carried the same guide in either the first or second 
position (Figure 10A). Subsequent Northern blot analyses of transfected cells showed three 
distinct RNA species, corresponding to a 200+ nt (likely unprocessed tandem RNA transcript), a 
~140 nt transcript (consistent with premature transcriptional termination signaled by the poly-U 
tract in the second scaffold), and a ~100 nt fully processed sgRNA (Figure 10B).  
 
When the target spacer is in the first position in the tsgRNA, we observed abundant fully 
processed sgRNA of the same size as individually U6-transcribed sgRNAs. However, when 
placed in the second position, there were only trace amounts of fully processed sgRNA present. 
Consistent with this, we observed that reversing spacer order in microdeletion assays could 
significantly alter the efficiency of genomic modification (data not shown). Furthermore, when 
testing other pairs of sgRNAs targeting different genomic loci, we observed that the same guide 
sequence typically has better activity when placed in the first rather than the second position 
(Figure 10C). These observations suggest that while most spacers are compatible with a single 
guide transcript, the sequence of the second spacer may be more likely to influence activity of 
the second sgRNA in the context of a tandem sgRNA.  
 
Pairing of sequence-divergent scaffolds results in better second spacer activity 
To optimize the activity of the second spacer, we devised an assay for assessing its activity by 
fluorescence cytometry. By targeting the second guide against Cas9 itself in a plasmid 
expressing Cas9-2A-GFP, we can assess indel activity by measuring the fluorescence fraction 
and intensity of transfected cells (Figure 11A). We observed that transfecting cells with single 
sgRNAs targeting Cas9 or co-delivering Cas9-targeting sgRNA with another sgRNA 29 
 
significantly reduced the mean fluorescence intensity (MFI) of the Cas9-2A-GFP-transfected 
GFP-positive fraction, whereas cells transfected with Cas9-2A-EGFP and a non-Cas9-targeting 
sgRNA maintained high MFI (Figure 11B).  
 
Given that each sgRNA scaffold needs to fold into a stable secondary structure, we hypothesized 
that a potential reason for the decreased activity of the second spacer may be due to secondary 
structure interactions not within a single but between the two sgRNA scaffolds. We surmised 
that the use of divergent, minimally homologous sgRNA scaffolds that are less likely to base-
pair with each other could reduce interactions between the pair and aid individual folding. To test 
this hypothesis, we designed a set of twelve distinct sgRNA scaffolds, each with the first guide 
targeting GRIN2B and the second targeting Cas9, and performed a pair-wise comparison of all 
scaffold combinations. Subsequent flow-cytometric analyses identified five potential candidate 
sgRNA scaffolds that significantly reduced both the MFI of the GFP-positive fraction as well as 
the overall percentage of GFP-positive cells; the levels of reductions are similar to those obtained 
by transfecting singly transcribed Cas9-targeting sgRNA (Figure 11C). Consistent with the 
notion that inter-scaffold interactions may be disrupting proper sgRNA folding and processing, 
most of the five scaffolds showed relatively poor activity when transcribed in tandem with highly 
homologous sgRNAs. Indeed, sequence alignment analysis of the twelve scaffolds showed that 
the pairs of tandem scaffolds that showed the highest activity had the greatest sequence 
divergence between the two sgRNAs (Figure 12). In summary, tandem-arrayed sgRNAs 
represents a potentially useful approach for co-delivery of two sgRNAs in a single RNA 
transcript. While some guide sequences appear to function well in the second position, 
optimization of the sgRNA architecture to maximize inter-scaffold sequence divergence and 
improve structural stability will likely aid processing and activity of tandem sgRNAs.   30 
 
Discussion 
Double nicking approach to genome editing with CRISPR 
Specificity is of paramount importance when introducing permanent genomic alterations, 
especially for highly sensitive applications such as gene therapy or studies aimed at linking 
causal genetic variants with biological processes or disease phenotypes. Designer nucleases such 
as ZFNs
62 and TALENs
63 have reported off-target activities over 15%. Given that both 
approaches are based on complex, evolved protein-DNA interactions, prediction or optimization 
of specificity through protein engineering can prove quite challenging. Nonetheless, efforts have 
been made to increase TALEN specificity, such as extending the number of bases recognized by 
protein monomers. 
 
Strategies for improving the targeting accuracy of the CRISPR-Cas system can optimize either of 
its two essential components - the Cas9 nuclease or sgRNA. While work in our lab has shown 
that extending the guide length does not improve specificity
53, it has recently been reported that 
shorter guide lengths could potentially significantly decrease non-specific activity at known off-
target sites
64. However, given that shorter guide sequence also increases the number of possible 
similar targets across a genome, it remains to be seen whether this strategy will decrease overall 
genome-wide off-target mutation frequencies. Here, we have demonstrated that combining two 
sgRNAs with Cas9 nickases is able to effectively generate DSBs while avoiding mutagenic 
events arising from single-stranded DNA break mutations as they are typically repaired with 
high fidelity
53. 
 
In the context of delivering gene repair or replacement templates, Cas9n nicking of DNA with a 
single sgRNA has been previously shown to facilitate HDR without generating indels
39. 31 
 
However, it is substantially less efficient at doing so relative to wild-type Cas9, and can be 
susceptible to differences in HDR efficiency among different cell types
48,52. However, we have 
demonstrated that using two closely approximated guides to target the Cas9n nickase to the same 
genomic locus can mediate HDR at high efficiencies while keeping off-target modifications to 
background levels. Moreover, the characterization of spacing parameters governing successful 
Cas9 double nickase-mediated gene targeting reveals an effective window of over 100-bp in 
which sgRNAs targeting opposite strands can be paired for double-nicking applications, allowing 
for a high degree of flexibility in their design. We have additionally demonstrated that double 
nicking-mediated indel frequencies are comparable to those of wild-type Cas9 modification at 
multiple loci in both human and mouse cells, confirming the reproducibility of this strategy for 
high-precision genome engineering.  
 
Though the ability to potentiate specific, targeted indel mutations greatly enables functional 
analyses by gene knock-out, the use of double-nicking to precisely target homologous 
recombination has practical implications in the generation of model systems and organisms. It 
has been reported that blastocyst injection of Cas9 nuclease with sgRNA and HDR template can 
generate conditional and reporter mice in a single step
59. While this finding immensely 
streamlines an otherwise laborious and prolonged process, the relatively high dose of Cas9 
mRNA and guide RNA injected into each blastocyst can become a real concern for off-target 
modifications. Indeed, concurrent work by collaborators and other members of the lab has 
already demonstrated that analogous blastocyst delivery of Cas9n with two sgRNAs can induce 
efficient targeted gene modification at the mouse Mecp2 locus
53. Further studies investigating 
the efficiency and specificity of the double-nicking approach in facilitating homologous 
recombination in the context of mouse model generation will be immensely informative.  32 
 
 
While significant off-target mutagenesis has been previously reported for Cas9 nucleases in 
human cells
48,49, the double-nicking approach provides a generalizable solution for rapid and 
accurate genome editing. Even though double-nicking is conceptually similar to ZFN- and 
TALEN-based genome editing systems, which utilize hemi-nuclease domains to induce DSBs, 
the ease, flexibility, and improved predictably of using an RNA-guided DNA targeting system 
significantly increases its potential downstream applications. Given that it has been observed that 
cooperative nicking at off-target sites can still occur in the context of ZFNs and TALENs, 
significant and thorough characterization of the true genome-wide off-target activity of the 
CRISPR-Cas system is still prerequisite to its further development as means of efficient, 
ultrahigh-precision genome editing. Even so, we believe that double nicking with Cas9n 
represents a solid step-forward in establishing CRISPR-Cas system as a versatile tool for genome 
manipulation in both basic science research and medicine.  
 
sgRNA optimization and creation of tandem guide RNAs 
Following the initial derivation of the chimeric sgRNA
41 from elements of tracrRNA and crRNA, 
the subsequent sp85 sgRNA scaffold
40,48 was developed from full-length tracrRNA and has 
become the most commonly architecture used for genome editing applications. However, aside 
from relatively few studies aimed at improving sgRNA stability
46,57, there has not yet been any 
reported fine mapping of sgRNA structure-function relationships or optimization of the sgRNA 
architecture through sequence replacement. The targeted, functional studies we performed have 
identified a number of regions within the sgRNA that may be amenable to further modification 
or addition of functional groups that may broaden the range of applications for the CRISPR-Cas9 
system. Notably, despite having tested a wide-range of scaffold modifications, we observed few 33 
 
changes that significantly improve the indel activity of Cas9. Further elucidation of the structure-
function relationship of the sgRNA interacting with its nuclease will be informative in making 
more targeted changes to both the sgRNA and Cas9 simultaneously that may allow further gains 
in on-target efficiency.  
 
The ribonuclease RNAseIII has been shown as necessary for processing and maturation of the 
crRNA following binding to tracrRNA in the type II CRISPR systems
37. However, processing at 
the 5’ end remains largely unknown in both microbial and eukaryotic contexts. A recent report 
investigating processing of Neisseria spp. CRISPR RNA processing identified transcriptional 
promoters located in the direct repeat preceding each spacer sequence that drives transcription of 
individual crRNA units
65. We have previously observed that lengthening of the spacer sequence 
to 30-nt does not result in a longer sgRNA: Northern blot analysis shows still the same length 
transcript as with sgRNAs with 20-nt guide sequences
53. Furthermore, our observation that 
sgRNA units can be fully processed – albeit at low levels – from the second position of the 
tsgRNA might point to the existence of potential endonucleases involved with end-maturation of 
sgRNAs.  
 
RNA-sequencing analyses have shown that spacers located at the promoter-proximal end of the 
CRISPR arrays tend to be of higher abundance than those located more distally, suggesting that 
transcriptional processivity may be an important parameter in determining relative efficiency of 
mature crRNA units
66. Consistent with our findings, this study also reports that certain spacer 
sequences predicted to form secondary interactions with adjacent RNA are often under-
represented. Thus, as we begin to develop synthetic CRISPR arrays, consideration of spacer 
sequence is likely to become of increasing importance.  34 
 
 
There have been a number of recent studies using CRISPR-Cas9 lentiviral libraries for genome-
wide knockout screens that have shown greater reproducibility and sensitivity than analogous 
RNAi-libraries
67,68. The ability to simultaneously deliver more than a single guide RNA on a 
single vector would be particularly interesting in the context of lentiviral screening 
methodologies, which would open the door for both high-throughput deletion as well as pairwise 
screens. In the context of commonly used shRNA libraries, the propensity of lentivirus to 
recombine has limited our ability to drive expression of multiple short RNAs from a single 
vector with the requirement of utilizing multiple unique promoters
26. Although it remains to be 
seen how many sgRNAs can be efficiently arrayed in tandem, this approach allows for a single 
promoter to drive expression of at least two sgRNAs. Furthermore, the knowledge that sequence-
divergent yet structurally similar sgRNA scaffolds can remain active will be useful in a variety 
of applications where recombination between structural elements has been a limitation.  
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Conclusions and Future Directions 
The!CRISPR4Cas!system!is!a!bacterial!adaptive!immune!system!that!is!able!to!induce!
double4stranded!DNA!breaks!(DSB)!in!a!multiplex4able,!sequence4specific!manner!that!has!
been!re4constituted!within!mammalian!cell!systems39441.!While!well4characterized!
programmable!DNA4targeting!proteins!and!nucleases!already!existed,!CRISPR4Cas!differs!
from!these!technologies!in!a!number!of!fundamental!ways.!!
!
First,!the!use!of!RNA!rather!than!protein!to!mediate!DNA!sequence!recognition!was!new!to!
genome!editing!technologies!and!represented!an!exciting!new!opportunity!that!could!
potentially!open!doors!to!new!applications!in!much!the!same!way!as!the!development!of!
RNAi!technology!had!done.!Just!as!the!use!of!short!RNAs!to!facilitate!targeted!gene!silencing!
readily!allowed!the!prediction!of!both!on4!and!off4target!activity,!there!was!almost!
immediate!concern!regarding!the!potential!for!off4target!mutagenesis!in!the!CRISPR/Cas!
system48,49,69!Through!the!development!of!the!double4nicking!strategy!described!above,!we!
were!able!to!demonstrate!that!the!RNA4guided!DNA!endonuclease!Cas9!could!be!modified!
to!minimize!off4target!potential!while!largely!maintaining!on4target!activity!in!a!
generalizable!and!predictable!way53.!Future!studies!examining!more!in4depth!the!target!
specificity!of!Cas9!and!Cas9n!beyond!just!genome4wide!predicted!off4target!sites!as!well!as!
the!development!and!characterization!of!new!Cas9!nickases!will!be!key!in!continuing!to!
validate!the!CRISPR/Cas!system!as!a!robust!and!reliable!system!for!genome!editing.!
Furthermore,!careful!investigation!of!the!Cas9::sgRNA!interactions!through!structure!
function!studies!will!likely!shed!light!on!rational!means!of!further!optimizing.!!
!
The!ease!of!both!delivering!multiple!sgRNAs!and!generating!new!guides!RNAS!for!targeting!36 
 
Cas9!represents!a!key!addition!to!the!genome!editing!toolbox.!In!the!case!of!the!former,!the!
ability!to!easily!multiplex!gene!targeting!has!allowed!the!expansion!of!the!genome!editing!
repertoire!to!include!not!just!small!indel!induction!and!gene!replacement!approaches!but!
also!creation!of!targeted!genomic!microdeletions39!and!simultaneous!targeting!of!multiple!
alleles!at!once59,60.!In!the!latter,!CRISPR4Cas!has!made!possible!the!creation!of!large!pooled!
libraries!of!sgRNAs!which!have!been!used!to!conduct!genome4wide!knock4out!screens67,68.!
In!the!latter!part!of!this!thesis,!I!presented!work!focused!on!further!achieving!true!
multiplex!genome!editing!capabilities!for!the!CRISPR4Cas!system.!The!ability!to!reliably!
deliver!two!or!more!active!sgRNAs!as!a!single!unit!would!allow!us!to!ask!very!different!
questions!in!the!context!of!both!in#vivo!modeling!as!well!as!high4throughput!screening!
methods.!!Ongoing!and!future!work!will!be!devoted!towards!the!thorough!characterization!
and!optimization!of!the!tandem!sgRNA!arrays!for!new!and!exciting!applications.!!
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Tables and Figures 
 
Figure 1. Paired sgRNAs induce indels via double-nicking with the nickase Cas9n 
(A) Schematic illustrating DNA double strand break using a pair of Cas9 D10A nickases (Cas9n). 
Two sgRNA target Cas9n to nick both strands of DNA. The D10A mutation renders Cas9 
capable of only cleaving the DNA strand that is complementary to the sgRNA. The offset 
distance refers to the length of DNA between the closest ends of the paired sgRNAs, in this case 
4bp. (B) Representative gel image showing Cas9n mediated indel in the EMX1 locus of the 
human genome, as detected using the SURVEYOR nuclease assay with 650bp band representing 
the unmodified genomic target and bands around 300bp indicating the presence of indels. 
 
Figure adapted from Ran et al.
53 
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Figure 2. Double-nicking is able to induce indels  
(A) Graphs showing indel frequency corresponding to indicated sgRNA offset distances across 
three different human genes: EMX1, DYRK1A, GRIN2B. (B) As an example, sequence of the 
human EMX1 locus targeted by Cas9n. sgRNA target sites and PAMs are indicated by blue and 
magenta bars respectively. Below, selected sequences showing representative indels. 
 
Figure adapted from Ran et al.
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Figure 3. Double nicking strategy is able to facilitate homologous recombination 
(A) Schematic illustrating HDR targeted via a single stranded oligodeoxynucleotide (ssODN) 
template at a DSB created by a pair of Cas9n. Successful recombination at the DSB site 
introduces a HindIII restriction site. (B) Restriction digest assay gel showing successful insertion 
of HindIII cleavage sites by double nicking-facilitated HDR in HEK 293FT cells. Upper bands 
are unmodified template; lower bands are HindIII cleavage product. (C) Double nicking 
enhances HDR in HUES62 cells. HDR frequencies determined using deep sequencing. (n = 3; 
error bars show mean ± s.e.) 
 
Figure adapted from Ran et al.
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Figure 4. Characterization of double nicking spacing for homologous recombination 
Schematic illustrating HDR with ssODN template (shown in blue, introduced HindIII site in red). 
Red arrowheads indicate binding site of respective sgRNA with black bars corresponding 
putative overhangs resulting from paired nicking activity. Panels at right show efficiency of 
recombination with the indicated sgRNA pairs, overhang length and type, and offset distances 
between paired sgRNAs.  
 
Figure adapted from Ran et al.
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Figure 5. Double-nicking reduces non-specific activity at known off-target sites 
(A) Schematic showing the target human EMX1 locus and sgRNA target sites. Genomic off-
target sites for the right sgRNA are listed below. Off-target sites were identified previously as 
described in Hsu et al
48. (B) SURVEYOR gels showing modification at the on-target site by 
Cas9n with two sgRNAs as well as by wild-type Cas9 with individual sgRNA. Indels at off-
target 5 were only observed for wild-type Cas9 with sgRNA 1. (C) The levels of off-target 
modification are quantified using deep sequencing at all five off-target loci.  (D) Specificity 
comparison of Cas9n and wild-type Cas9. The specificity ratio is calculated by taking the ratio of 
on-target and off-target modification rates. (n = 3; error bars show mean ± s.e.) 
 
Figure adapted from Ran et al.
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Figure 6. Rational mutagenesis of sgRNA architecture 
(A) Schematic of the chimeric sgRNA architecture with 20-bp guide sequence encoding for the 
target specificity. The different regions of the sgRNA interrogated by mutagenesis are named 
and highlighted above. (B) Description of mutations made and corresponding indel activity at 
human EMX1 locus 
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Figure 7. Distal hairpin and DDR stabilization retains comparable indel activity  
Schematic showing sequence of three alternative scaffold architectures aimed at stabilization of 
the hairpins with changes base-pairs denoted in black. Indel-inducing activity of corresponding 
scaffolds compared to the wild-type sp85 architecture is shown at right.  
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Figure 8. U6-driven tandem guide RNAs are able to efficiently target two genomic loci  
(A) Schematic illustrating a tandem sgRNA (2 sgRNAs connected by a linker) driven by a single 
U6 promoter. Images of PAGE gels of SURVEYOR assays demonstrate that tsgRNAs using 
modified RNA scaffolds delivered with the nickase Cas9n or wild-type Cas9 are able to induce 
genomic indels or microdeletions, (B and C, respectively) with frequencies comparable to co-
delivery of two independent sgRNAs.  
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Tandem Linker  Length  Sequence 
0  0 
  4  4  ATTA 
8  8  AATTATTA 
12  12  AATTATTAATTA 
16  16  AATTATTAATTATAAT 
Direct Repeat A  16  GTTTTAGAGCTATGCT 
Direct Repeat B  20  GTTTTGAATGGTCCCAAAAC 
Full Direct Repeat  36  GTTTTAGAGCTATGCTGTTTTGAATGGTCCCAAAAC 
Figure 9. Optimization of tandem sgRNA linker length and structure 
Gel quantification of band intensities from PCR amplification of the human EMX1 target loci 
comparing relative abundance of wild-type and modified DNA with varying tandem linkers of 0, 
4, 8, 12, 16 base pairs, half direct repeat or full direct repeat (listed in bottom panel).  
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Figure 10. Tandem guide RNAs are efficiently processed in only the first position 
(A) Schematic showing tandem guide RNA scaffolds encoding for either EMX1.3 or EMX63 in 
the first or second position with position of Emx1.3 Northern probe shown in red. (B) Northern 
blot analysis examining processing of tandem sgRNA in cells. (C) SURVEYOR assay 
examining independent sgRNA activity targeting two genomic loci, DYRK1A and GRIN2B. 
The three left lanes in both panels are tsgRNAs targeting DYRK1A in the first position and 
GRIN2B in the second position. Conversely, three right lanes target GRIN2B first and then 
DYRK1A second.  
   54 
 
 
   
 
Figure 11. Optimization of tsgRNA scaffold pairings 
(A) Schematic of tandem scaffold design with first spacer targeting Grin2B using Scaffold A and 
second spacer targeting Cas9 itself using Scaffold B in a Cas9-T2A-GFP expressing plasmid. (B) 
Single U6-guide controls show both an increase in the percentage of GFP-negative cells as well 
as a decrease in mean fluorescence intensity of the positive fraction. (C) 12x12 matrix of tandem 
scaffold pairings and results of subsequent analyses by flow cytometry.  
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Figure 12. Tandem pairs between divergent scaffolds improve second spacer activity 
Sequence alignment of the sgRNA scaffolds used in the previous study to the sp85 scaffold. 
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Table 1. List of sgRNA pairs to identify optimal spacing.  
 
N.D.: Not detected. 
Table S1. List of sgRNA pairs used with Cas9 nickase (D10A) to identify the optimal target site spacing for double nicking across multiple genes, related to Figure 2. N.D.: Not detected. N.T.: Not tested
Gene Overhang 
Length (bp)
Overhang 
Type
Offset Length 
(bp)
Left   
sgRNA ID
Right sgRNA 
ID  
Cas9n with left and right 
sgRNA indel (%) guide sequence (5' to 3') PAM left sgRNA with wildtype 
Cas9 indel (%) guide sequence (5' to 3') PAM
right sgRNA with 
wildtype Cas9 indel 
(%)
EMX1 148 3' -182 15 4 N.D. TGCGCCACCGGTTGATGTGA TGG 13.15 AGGCCCCAGTGGCTGCTCTG GGG 27.29
EMX1 101 3' -135 23 1 N.D. ACTCTGCCCTCGTGGGTTTG TGG 24.7 GAGTCCGAGCAGAAGAAGAA GGG 21.9
EMX1 48 3' -82 23 17 N.D. ACTCTGCCCTCGTGGGTTTG TGG 24.7 CACGAAGCAGGCCAATGGGG AGG 13.57
EMX1 25 3' -59 10 13 N.D. CAAACGGCAGAAGCTGGAGG AGG 26.15 GGAGCCCTTCTTCTTCTGCT CGG 33.17
EMX1 15 3' -49 4 5 N.D. AGGCCCCAGTGGCTGCTCTG GGG 27.29 GGGGCACAGATGAGAAACTC AGG 26.56
EMX1 8 3' -42 7 9 N.D. TGAAGGTGTGGTTCCAGAAC CGG 36.02 GCCGTTTGTACTTTGTCCTC CGG 30.49
EMX1 26 5' -8 9 19 13.7 ± 1.27 GCCGTTTGTACTTTGTCCTC CGG 9.82 GGCAGAGTGCTGCTTGCTGC TGG 26.15
EMX1 30 5' -4 9 10 19.72 ± 0.32 GCCGTTTGTACTTTGTCCTC CGG 30.49 CAAACGGCAGAAGCTGGAGG AGG 22.06
EMX1 31 5' -3 6 7 21.35 ± 2.23 TCACCTGGGCCAGGGAGGGA GGG 10.75 TGAAGGTGTGGTTCCAGAAC CGG 36.02
EMX1 34 5' 0 15 16 26.89 ± 1.54 TGCGCCACCGGTTGATGTGA TGG 13.15 TTGCCACGAAGCAGGCCAAT GGG 13.77
EMX1 38 5' 4 15 17 36.31 ± 2.97 TGCGCCACCGGTTGATGTGA TGG 14.49 CACGAAGCAGGCCAATGGGG AGG 13.57
EMX1 51 5' 17 5 7 31.12 ± 0.25 GGGGCACAGATGAGAAACTC AGG 26.56 TGAAGGTGTGGTTCCAGAAC CGG 36.02
EMX1 54 5' 20 5 8 32.41 ± 3.68 GGGGCACAGATGAGAAACTC AGG 26.56 AGGTGTGGTTCCAGAACCGG AGG 35.53
EMX1 65 5' 31 6 10 13.45 ± 1.99 TCACCTGGGCCAGGGAGGGA GGG 10.75 CAAACGGCAGAAGCTGGAGG AGG 26.15
EMX1 69 5' 35 6 11 12.39 ± 1.29 TCACCTGGGCCAGGGAGGGA GGG 10.75 CGGCAGAAGCTGGAGGAGGA AGG 22.06
EMX1 76 5' 42 9 14 21.71 ± 1.66 GCCGTTTGTACTTTGTCCTC CGG 30.49 AGGGCTCCCATCACATCAAC CGG 41.27
EMX1 85 5' 51 5 10 21.89 ± 1.88 GGGGCACAGATGAGAAACTC AGG 26.56 CAAACGGCAGAAGCTGGAGG AGG 26.15
EMX1 95 5' 61 6 12 5.88 ± 1.81 TCACCTGGGCCAGGGAGGGA GGG 10.75 TGAGTCCGAGCAGAAGAAGA AGG 29.06
EMX1 135 5' 101 5 14 15.78 ± 2.19 GGGGCACAGATGAGAAACTC AGG 26.56 AGGGCTCCCATCACATCAAC CGG 41.27
EMX1 145 5' 111 6 16 N.D. TCACCTGGGCCAGGGAGGGA GGG 10.75 TTGCCACGAAGCAGGCCAAT GGG 13.77
EMX1 181 5' 147 6 18 N.D. TCACCTGGGCCAGGGAGGGA GGG 10.75 TCACCTCCAATGACTAGGGT GGG 25.14
EMX1 201 5' 167 5 18 N.D. GGGGCACAGATGAGAAACTC AGG 26.56 TCACCTCCAATGACTAGGGT GGG 25.14
EMX1 222 5' 188 6 19 N.D. TCACCTGGGCCAGGGAGGGA GGG 10.75 GGCAGAGTGCTGCTTGCTGC TGG 10.75
EMX1 242 5' 208 5 19 N.D. GGGGCACAGATGAGAAACTC AGG 26.56 GGCAGAGTGCTGCTTGCTGC TGG 17.22
DYRK1A 164 3' -198 34 47 N.D. ATCTGGTCAGAATATGATAA AGG 10.65 ± 2.05 AACCTCACTTATCTTCTTGT AGG 19.02 ± 4.32
DYRK1A 105 3' -139 35 47 N.D. GTCACTGTACTGATGTGAAT TGG 16.71 ± 2.47 AACCTCACTTATCTTCTTGT AGG 17.04 ± 1.30
DYRK1A 66 3' -100 36 48 N.D. CATCTGAAGGCCAGCAGCAT TGG 8.82 ± 1.01 CTCACTTATCTTCTTGTAGG AGG 18.79 ± 2.71
DYRK1A 25 3' -59 35 49 N.D. GTCACTGTACTGATGTGAAT TGG 17.83 ± 0.43 CCATGCTGCTGGCCTTCAGA TGG 17.15 ± 3.29
DYRK1A 4 3' -38 37 31 N.D. TGATAAGGCAGAAACCTGTT TGG 4.95 ± 0.66 GCCAAACATAAGTGACCAAC AGG 16.38 ± 3.39
DYRK1A 17 5' -17 38 47 N.D. GAAGATAAGTGAGGTTTAAA AGG 5.30 ± 1.98 AACCTCACTTATCTTCTTGT AGG 24.18 ± 3.22
DYRK1A 21 5' -13 39 33 10.54 ± 0.63 GTATCATTTGACATATCTAA TGG 26.90 ± 1.17 TGTCAAATGATACAAACATT AGG 29.69 ± 0.86
DYRK1A 25 5' -9 40 49 2.33 ± 0.11 CAGCATGGAATGAAAATGAC CGG 3.33 ± 0.56 CCATGCTGCTGGCCTTCAGA TGG 20.43 ± 2.40
DYRK1A 29 5' -5 41 50 27.76 ± 0.84 GCAGCATGGAATGAAAATGA CGG 17.84 ± 5.46 GCTGCTGGCCTTCAGATGGC TGG 21.92 ± 3.46
DYRK1A 33 5' -1 34 51 10.42 ± 0.90 ATCTGGTCAGAATATGATAA AGG 9.13 ± 2.32 TCAGCAACCTCTAACTAACC AGG 24.14 ± 2.95
DYRK1A 35 5' 1 42 52 7.63 ± 0.51 GTGCAAGCCGAACAGATGAA AGG 6.65 ± 2.19 TCATTTTCATTCCATGCTGC TGG 20.61 ± 3.64
DYRK1A 36 5' 2 28 29 38.46 ± 0.74 GGAGTATCAGAAATGACTAT TGG 20.88 ± 9.09 GGAGTATCAGAAATGACTAT TGG 30.3 ± 0.7
DYRK1A 41 5' 7 30 31 34.41 ± 0.87 GGTCACTGTACTGATGTGAA TGG 25.68 ± 5.95 GCCAAACATAAGTGACCAAC AGG 33.1 ± 0.4
DYRK1A 42 5' 8 43 31 38.36 ± 0.32 TCACTGTACTGATGTGAATG GGG 24.68 ± 4.58 GCCAAACATAAGTGACCAAC AGG 29.46 ± 3.30
DYRK1A 43 5' 9 32 33 28.97 ± 0.32 GTTCCTTAAATAAGAACTTT AGG 23.60 ± 2.56 TGTCAAATGATACAAACATT AGG 22.4 ± 1.6
DYRK1A 46 5' 12 44 53 11.90 ± 1.65 TCCTACAAGAAGATAAGTGA AGG 6.57 ± 1.36 CATGCAAACCTTCATCTGTT CGG 30.42 ± 1.14
DYRK1A 77 5' 43 36 31 6.63 ± 0.27 CATCTGAAGGCCAGCAGCAT TGG 10.02 ± 1.17 GCCAAACATAAGTGACCAAC AGG 22.92 ± 5.16
DYRK1A 86 5' 52 38 52 N.D. GAAGATAAGTGAGGTTTAAA AGG 2.90 ± 0.82 TCATTTTCATTCCATGCTGC TGG 17.30 ± 1.62
DYRK1A 97 5' 63 38 49 N.D. GAAGATAAGTGAGGTTTAAA AGG 2.16 ± 0.48 CCATGCTGCTGGCCTTCAGA TGG 24.75 ± 2.50
DYRK1A 131 5' 97 45 52 N.D. TATCATTTGACATATCTAAT TGG 8.21 ± 2.83 TCATTTTCATTCCATGCTGC TGG 14.61 ± 4.10
DYRK1A 155 5' 121 44 31 N.D. TCCTACAAGAAGATAAGTGA AGG 9.99 ± 4.12 GCCAAACATAAGTGACCAAC AGG 19.74 ± 2.91
DYRK1A 191 5' 157 46 52 N.D. AACTTTTCTAACTACAAACA AGG 5.74 ± 2.24 TCATTTTCATTCCATGCTGC TGG 21.37
GRIN2B 165 3' -199 70 82 N.D. CCAACACCAACCAGAACTTG GGG 2.95 ± 0.21 CTGGTAGATGGAGTTGGGTT TGG 17.25 ± 1.30
GRIN2B 67 3' -101 71 83 N.D. ACAGCAATGCCAATGCTGGG GGG 18.00 ± 2.31 AGTGCTGTTCTCCCAAGTTC TGG 28.64 ± 0.69
GRIN2B 42 3' -76 72 84 N.D. GTGGAAATCATCTTTCTCGT TGG 14.56 ± 7.84 GGCATTGCTGTCATCCTCGT GGG 21.26 ± 2.68
GRIN2B 16 3' -50 73 85 N.D. TCTGCTGCCTGACACGGCCA AGG 4.24 ± 0.79 TCCCAAGTTCTGGTTGGTGT TGG 19.64 ± 0.23
GRIN2B 2 3' -36 74 86 N.D. CGAGCTCTGCTGCCTGACAC CGG 2.99 ± 0.31 TTGGCCGTCCTGGCCGTGTC AGG 4.74 ± 0.15
GRIN2B 9 5' -25 75 87 1.04 ± 0.53 TCCTTGATGGCCACCTCGTC CGG 2.25 ± 1.08 TTCCGACGAGGTGGCCATCA AGG 17.13 ± 2.90
GRIN2B 18 5' -16 76 88 5.93 ± 1.25 ATGACAGCAATGCCAATGCT TGG 16.46 ± 2.28 TGGCATTGCTGTCATCCTCG TGG 16.35 ± 1.25
GRIN2B 23 5' -11 77 88 2.28 ± 0.34 AGCAATGCCAATGCTGGGGG GGG 3.19 ± 0.51 TGGCATTGCTGTCATCCTCG TGG 15.17 ± 2.02
GRIN2B 28 5' -6 78 86 1.45 ± 0.12 GCCAACACCAACCAGAACTT TGG 17.80 ± 2.30 TTGGCCGTCCTGGCCGTGTC AGG 4.46 ± 1.35
GRIN2B 30 5' -4 69 85 11.80 ± 0.29 GGAGAACAGCACTCCGCTCT TGG 21.80 ± 1.40 TCCCAAGTTCTGGTTGGTGT TGG 21.33 ± 0.63
GRIN2B 33 5' -1 76 65 24.24 ± 0.23 ATGACAGCAATGCCAATGCT TGG 19.48 ± 1.88 CCTCGTGGGCACTTCCGACG AGG 21.19 ± 3.42
GRIN2B 34 5' 0 79 65 20.83 ± 0.95 TGACAGCAATGCCAATGCTG GGG 21.44 ± 3.02 CCTCGTGGGCACTTCCGACG AGG 24.11 ± 0.14
GRIN2B 36 5' 2 58 59 31.76 ± 1.00 CCGGCCAAGACCTTGAAGCC AGG 32.50 ± 0.50 CTGGTTGTAGGATTTGAGTT AGG 26.7 ± 2.9
GRIN2B 38 5' 4 54 55 34.45 ± 0.45 TATTACAGAATGAGAGACTG TGG 30.90 ± 1.40 TTATTTCTGAAGAATATTAA AGG 27.6 ± 2.5
GRIN2B 38 5' 4 56 57 44.22 ± 0.55 AAAAGACCTAAACAAAAGAA TGG 23.20 ± 2.10 TGTGTGAGGATAAAAGAGTT GGG 29.4 ± 2.7
GRIN2B 38 5' 4 77 65 9.60 ± 0.25 AGCAATGCCAATGCTGGGGG GGG 4.19 ± 0.58 CCTCGTGGGCACTTCCGACG AGG 21.78 ± 1.70
GRIN2B 40 5' 6 60 61 42.54 ± 1.39 TCAGAGCTTCCTGACACCCA TGG 14.20 ± 1.50 AATACCTAGTTACAGGCATT TGG 24.8 ± 1.0
GRIN2B 45 5' 11 76 87 18.96 ± 0.93 ATGACAGCAATGCCAATGCT TGG 20.45 ± 0.98 TTCCGACGAGGTGGCCATCA AGG 13.21 ± 0.74
GRIN2B 50 5' 16 77 87 5.33 ± 0.57 AGCAATGCCAATGCTGGGGG GGG 4.93 ± 2.06 TTCCGACGAGGTGGCCATCA AGG 12.51 ± 1.21
GRIN2B 89 5' 55 80 89 7.31 ± 0.83 GAGAACAGCACTCCGCTCTG GGG 3.09 ± 0.54 CAGAAGAGCCCCCCCAGCAT TGG 25.02 ± 1.86
GRIN2B 105 5' 71 78 90 10.56 ± 1.21 GCCAACACCAACCAGAACTT TGG 25.29 ± 1.65 CGTGGGCACTTCCGACGAGG TGG 23.32 ± 0.78
GRIN2B 132 5' 98 81 67 2.66 ± 0.89 CTGCCTGACACGGCCAGGAC CGG 4.34 ± 0.62 TGATTTCCACCATCTCTCCG TGG 20.95 ± 0.79
GRIN2B 175 5' 141 80 67 N.D. GAGAACAGCACTCCGCTCTG GGG 2.96 ± 0.93 TGATTTCCACCATCTCTCCG TGG 19.77 ± 2.20
GRIN2B 231 5' 197 81 91 N.D. CTGCCTGACACGGCCAGGAC CGG 6.17 ± 2.09 TGACCGGAAGATCCAGGGGG TGG 23.36 ± 2.34
right sgRNA target site left sgRNA target site57 
 
Table 2: List of sgRNAs used in this study
 
Table S2. List of sgRNAs used in this study. Related to Figure 2.
gene sgRNA ID guide sequence (5' to 3') PAM strand species
EMX1 1 GAGTCCGAGCAGAAGAAGAA GGG + H. sapiens
EMX1 2 GGAAGGGCCTGAGTCCGAGCAGAAGAAGA GGG + H. sapiens
EMX1 3 GGCCTCCAAGGAGTCCGAGCAGAAGAAGAA GGG + H. sapiens
EMX1 4 AGGCCCCAGTGGCTGCTCTG GGG + H. sapiens
EMX1 5 GGGGCACAGATGAGAAACTC AGG — H. sapiens
EMX1 6 TCACCTGGGCCAGGGAGGGA GGG — H. sapiens
EMX1 7 TGAAGGTGTGGTTCCAGAAC CGG + H. sapiens
EMX1 8 AGGTGTGGTTCCAGAACCGG AGG + H. sapiens
EMX1 9 GCCGTTTGTACTTTGTCCTC CGG — H. sapiens
EMX1 10 CAAACGGCAGAAGCTGGAGG AGG + H. sapiens
EMX1 11 CGGCAGAAGCTGGAGGAGGA AGG + H. sapiens
EMX1 12 TGAGTCCGAGCAGAAGAAGA AGG + H. sapiens
EMX1 13 GGAGCCCTTCTTCTTCTGCT CGG — H. sapiens
EMX1 14 AGGGCTCCCATCACATCAAC CGG + H. sapiens
EMX1 15 TGCGCCACCGGTTGATGTGA TGG — H. sapiens
EMX1 16 TTGCCACGAAGCAGGCCAAT GGG + H. sapiens
EMX1 17 CACGAAGCAGGCCAATGGGG AGG + H. sapiens
EMX1 18 TCACCTCCAATGACTAGGGT GGG + H. sapiens
EMX1 19 GGCAGAGTGCTGCTTGCTGC TGG + H. sapiens
EMX1 20 GACATCGATGTCCTCCCCAT TGG — H. sapiens
EMX1 21 GTCACCTCCAATGACTAGGG TGG + H. sapiens
EMX1 22 GGGCAACCACAAACCCACGA GGG + H. sapiens
EMX1 23 ACTCTGCCCTCGTGGGTTTG TGG — H. sapiens
EMX1 24 CAAGCAGCACTCTGCCCTCG TGG — H. sapiens
EMX1 25 TTCTTCTTCTGCTCGGACTC AGG — H. sapiens
EMX1 26 CTCCCCATTGGCCTGCTTCG AGG — H. sapiens
EMX1 27 GTCACCTCCAATGACTAGGG TGG + H. sapiens
DYRK1A 28 GAACTTACCTGGTTAGTTAG AGG — H. sapiens
DYRK1A 29 GGAGTATCAGAAATGACTAT TGG + H. sapiens
DYRK1A 30 GGTCACTGTACTGATGTGAA TGG — H. sapiens
DYRK1A 31 GCCAAACATAAGTGACCAAC AGG + H. sapiens
DYRK1A 32 GTTCCTTAAATAAGAACTTT AGG — H. sapiens
DYRK1A 33 TGTCAAATGATACAAACATT AGG + H. sapiens
DYRK1A 34 ATCTGGTCAGAATATGATAA AGG — H. sapiens
DYRK1A 35 GTCACTGTACTGATGTGAAT TGG — H. sapiens
DYRK1A 36 CATCTGAAGGCCAGCAGCAT TGG — H. sapiens
DYRK1A 37 TGATAAGGCAGAAACCTGTT TGG — H. sapiens
DYRK1A 38 GAAGATAAGTGAGGTTTAAA AGG — H. sapiens
DYRK1A 39 GTATCATTTGACATATCTAA TGG — H. sapiens
DYRK1A 40 CAGCATGGAATGAAAATGAC CGG — H. sapiens
DYRK1A 41 GCAGCATGGAATGAAAATGA CGG — H. sapiens
DYRK1A 42 GTGCAAGCCGAACAGATGAA AGG — H. sapiens
DYRK1A 43 TCACTGTACTGATGTGAATG GGG — H. sapiens
DYRK1A 44 TCCTACAAGAAGATAAGTGA AGG — H. sapiens
DYRK1A 45 TATCATTTGACATATCTAAT TGG — H. sapiens
DYRK1A 46 AACTTTTCTAACTACAAACA AGG — H. sapiens58 
 
 
   
DYRK1A 47 AACCTCACTTATCTTCTTGT AGG + H. sapiens
DYRK1A 48 CTCACTTATCTTCTTGTAGG AGG + H. sapiens
DYRK1A 49 CCATGCTGCTGGCCTTCAGA TGG + H. sapiens
DYRK1A 50 GCTGCTGGCCTTCAGATGGC TGG + H. sapiens
DYRK1A 51 TCAGCAACCTCTAACTAACC AGG + H. sapiens
DYRK1A 52 TCATTTTCATTCCATGCTGC TGG + H. sapiens
DYRK1A 53 CATGCAAACCTTCATCTGTT CGG + H. sapiens
DYRK1A 54 TATTACAGAATGAGAGACTG TGG — H. sapiens
DYRK1A 55 TTATTTCTGAAGAATATTAA AGG + H. sapiens
DYRK1A 56 AAAAGACCTAAACAAAAGAA TGG — H. sapiens
DYRK1A 57 TGTGTGAGGATAAAAGAGTT GGG + H. sapiens
DYRK1A 58 CCGGCCAAGACCTTGAAGCC AGG — H. sapiens
DYRK1A 59 CTGGTTGTAGGATTTGAGTT AGG + H. sapiens
DYRK1A 60 TCAGAGCTTCCTGACACCCA TGG — H. sapiens
DYRK1A 61 AATACCTAGTTACAGGCATT TGG + H. sapiens
GRIN2B 62 GGTGATGATGCTCTTTGGGT CGG — H. sapiens
GRIN2B 63 TCTGTGATCTCATGTCTGAC CGG + H. sapiens
GRIN2B 64 CAGCAATGCCAATGCTGGGG GGG — H. sapiens
GRIN2B 65 CCTCGTGGGCACTTCCGACG AGG + H. sapiens
GRIN2B 66 TTTCTCGTGGGCATCCTTGA TGG — H. sapiens
GRIN2B 67 TGATTTCCACCATCTCTCCG TGG + H. sapiens
GRIN2B 68 GGAGAACAGCACTCCGCTCT GGG — H. sapiens
GRIN2B 69 CTGGTTGGTGTTGGCCGTCC TGG + H. sapiens
GRIN2B 70 CCAACACCAACCAGAACTTG GGG — H. sapiens
GRIN2B 71 ACAGCAATGCCAATGCTGGG GGG — H. sapiens
GRIN2B 72 GTGGAAATCATCTTTCTCGT TGG — H. sapiens
GRIN2B 73 TCTGCTGCCTGACACGGCCA AGG — H. sapiens
GRIN2B 74 CGAGCTCTGCTGCCTGACAC CGG — H. sapiens
GRIN2B 75 TCCTTGATGGCCACCTCGTC CGG — H. sapiens
GRIN2B 76 ATGACAGCAATGCCAATGCT TGG — H. sapiens
GRIN2B 77 AGCAATGCCAATGCTGGGGG GGG — H. sapiens
GRIN2B 78 GCCAACACCAACCAGAACTT TGG — H. sapiens
GRIN2B 79 TGACAGCAATGCCAATGCTG GGG — H. sapiens
GRIN2B 80 GAGAACAGCACTCCGCTCTG GGG — H. sapiens
GRIN2B 81 CTGCCTGACACGGCCAGGAC CGG — H. sapiens
GRIN2B 82 CTGGTAGATGGAGTTGGGTT TGG + H. sapiens
GRIN2B 83 AGTGCTGTTCTCCCAAGTTC TGG + H. sapiens
GRIN2B 84 GGCATTGCTGTCATCCTCGT GGG + H. sapiens
GRIN2B 85 TCCCAAGTTCTGGTTGGTGT TGG + H. sapiens
GRIN2B 86 TTGGCCGTCCTGGCCGTGTC AGG + H. sapiens
GRIN2B 87 TTCCGACGAGGTGGCCATCA AGG + H. sapiens
GRIN2B 88 TGGCATTGCTGTCATCCTCG TGG + H. sapiens
GRIN2B 89 CAGAAGAGCCCCCCCAGCAT TGG + H. sapiens
GRIN2B 90 CGTGGGCACTTCCGACGAGG TGG + H. sapiens
GRIN2B 91 TGACCGGAAGATCCAGGGGG TGG + H. sapiens59 
 
Table 3. List of sgRNA scaffolds used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
sgRNA Scaffold Length Sequence
Wild-type sp85 81 gttttagagctaGAAAtagcaagttaaaataaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Replace bulge with G-C pair 79 gttttagCgctaGAAAtagcGttaaaataaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Replace PDR with CCGG tract, remove bulge 79 gCCGGCgCgctaGAAAtagcGtGCCGGtaaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Replace PDR with CCGG tract, keep bulge 71 gCCGGCgCGAAAGtGCCGGtaaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Shorten PDR, remove bulge 81 gCCGGCgagctaGAAAtagcaagtGCCGGtaaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Replace PDR with CCCC tract 80 gccccagagctagaaatagcaagttggggtaaggctagtccgttatcaacttgaaaaagtggcaccgagtcggtgctttt
Bulge randomization 81 gttttagagctaGAAAtagcNNNNtaaaataaggctagtccgttatcaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Linker truncation, first half 72 gttttagagctaGAAAtagcaagttaaaataaggctagtacttGAAAaagtggcaccgAGTcggtgcTTTTT
Linker truncation, second half 63 gttttagagctaGAAAtagcaagttaaaatacttGAAAaagtggcaccgAGTcggtgcTTTTT
Linker scramble 81 gttttagagctaGAAAtagcaagttaaaatagatcgtatacatcattaacttGAAAaagtggcaccgAGTcggtgcTTTTT
Linker randomization 81 gttttagagctaGAAAtagcaagttaaaatNNNNNNNNNNNNNNNNNNacttGAAAaagtggcaccgAGTcggtgcTTTTT
Replace Stem 2 with G-C track 81 gttttagagctaGAAAtagcaagttaaaataaggctagtccgttatcaCGCCGAAAGGCGggcaccgAGTcggtgcTTTTT
Extend Stem 2 by 2 bp 85 gttttagagctaGAAAtagcaagttaaaataaggctagtccgttatcaacttgaGAAAtcaagtggcaccgAGTcggtgcTTTTT
Replace Stem 3 with G-C track 80 gttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggccccgcggcggggctttt
Lengthen Stem 3 (add 3bp) 84 gttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagtggcaccgaaagtttcggtgctttt
4558 82 gttttagagctaGAAAtagcaagttaaaataaggctagtccgttatcaCGCCGAAAGGCGggcaccgAGTcggtgccTTTTT
4561 92 gttttagagctaGAAAtagcaagttaaaataaggctagtccgttatcaccttgggccGAAAggcccaaggggcgccgAGTcggcgccTTTTT
4638 82 gttttagagccgGAAAcggcaagttaaaataaggctagtccgttatcaCGCCGAAAGGCGggcaccgAGTcggtgccTTTTT
Opt1CCCC 81 gccccagCgctaGAAAtagcaagttggggtaaggctagtccgttatcaCGCCGAAAGGCGggcaccgAGTcggtgcTTTTT
Opt1CTTC 81 gcttcagCgctaGAAAtagcaagttgaagtaaggctagtccgttatcaCGCCGAAAGGCGggcaccgAGTcggtgcTTTTT
Scrmbl1 92 gttttagatgcaattatgcaaagttaaaataaggctagtccgttatcaacttataccaataagtcatcgtcgagAAGctcgacgatgTTTTT
Scrmbl2 92 gttttagaactcattagagtaagttaaaataaggctagtccgttatcaacatgcaccagcatgttcaggattcaAAGtgaatcctgaTTTTT
ShScrmbl1 PolyC 82 gccccagatgcaattatgcaaagttggggtaaggcaagtccgttatcaaccgaccacggtcacgtcgAAGcgacgtgTTTTT
ShScrmbl1 CTTC 82 gcttcagatgcaattatgcaaagttgaagtaaggcaagtccgttatcacctgaccacagggtgtcgtAAGacgacacTTTTT
Shorter Scrmbl1 PolyC 77 gccccagaccattggaagttggggtaaggcaagtccgttatcaaccgaccacggtcacgtcgAAGcgacgtgTTTTT
Shorter Scrmbl1 CTTC 77 gcttcagaggattccaagttgaagtaaggcaagtccgttatcacctgaccacagggtgtcgtAAGacgacacTTTTT60 
 
Table 4. Primers used for SURVEYOR assays 
Primer 
Name 
Genomic 
Target  Sequence 
SUV901  EMX1  CCATCCCCTTCTGTGAATGT 
SUV902  EMX1  GGAGATTGGAGACACGGAGA 
DYRK1A-F  DYRK1A  GGAGCTGGTCTGTTGGAGAA 
DYRK1A-R  DYRK1A  TCCCAATCCATAATCCCACGTT 
GRIN2B-F  GRIN2B  CAGGAGGGCCAGGAGATTTG 
GRIN2B-R  GRIN2B   TGAAATCGAGGATCTGGGCG 
 
Table 5. Primers used to generate amplicons for NGS 
Primer Name  Sequence 
EMX1-F  GGAGGACAAAGTACAAACGGC 
EMX1-R  ATCGATGTCCTCCCCATTGG 
EMX1-HR-F  CCATCCCCTTCTGTGAATGT 
EMX1-HR-R  GGAGATTGGAGACACGGAGA 
EMX1-OT1.1-F  TGGGAGAGAGACCCCTTCTT 
EMX1-OT1.1-R  TCCTGCTCTCACTTAGACTTTCTC 
EMX1-OT1.2-F  GACATTCCTCCTGAGGGAAAA 
EMX1-OT1.2-R  GATAAAATGTATTCCTTCTCACCATTC 
EMX1-OT1.3-F  CCAGACTCAGTAAAGCCTGGA 
EMX1-OT1.3-R  TGGCCCCAGTCTCTCTTCTA 
EMX1-OT1.4-F  CACGGCCTTTGCAAATAGAG 
EMX1-OT1.4-R  CATGACTTGGCCTTTGTAGGA 
EMX1-OT1.5-F  TGGGGTTACAGAAAGAATAGGG 
EMX1-OT1.5-R  TTCTGAGGGCTGCTACCTGT 
 
 
 
 
 
 